2021年8月9日

普拉卡什梅农带来广泛的人工智能和企业软件技术全球领先的连接提供的长期护理管理新闻分享这篇文章分享本文帕洛阿尔托,加州8月9日,2021 / Glooko Inc .)从远程病人监控的主要提供者和数据管理平台在糖尿病和相关的慢性病,今天宣布任命Prakash梅农作为公司的首席技术官。作为成熟技术执行官拥有超过30年的企业软件开发的经验,梅农将深企业软件专业Glooko建筑最具创新的目标数字平台连接慢性病患者和他们的保健提供者,更好的健康结果。Glooko CTO Prakash梅农梅农在SaaS广泛记录,企业软件开发,AI技术领导和创业经验。除了企业应用程序开发,他的专长领域包括分布式系统集成、数据库(SQL和NoSql)云计算和构建和部署的机器学习(ML)模型来生产规模。他已经建立并领导团队需要毫升的交付解决方案,业务分析、应用程序开发、移动开发和开放API开发。最近他担任首席技术官Genalyte并发表多抗原分析算法COVID-19抗体测试中使用毫升三周,导致投资真的(谷歌健康)。在此之前,梅农花了7年的首席技术官的角色,在BaseHealth临时首席执行官和董事会成员。在BaseHealth他的团队构建和交付5小说用毫升和深度学习人工智能产品准确预测世界上发生的最严重的疾病。他的团队架构一个毫升平台,处理3.5亿数据点超过263000生活在混合云技术。梅农独特的软件的角度和他丰富的背景在创建和扩展的大规模云软件系统将Glooko全球患者基础服务,医疗服务提供者和技术合作伙伴,在这个行业内解决标准化和规模的挑战数字医疗。 Glooko currently provides remote patient management and connected care platforms in diabetes and related chronic conditions such as obesity and hypertension. With recent funding, the Company is expanding into additional indications and global markets. "I'm excited to join Glooko and help the team scale to deliver superior platforms for connecting patients with their healthcare providers for better care," Menon said. "I'm impressed with Glooko's proven technology that has shown to improve outcomes for people with chronic diseases, and I'm ready to help make that happen at a whole new level." Russ Johannesson, Chief Executive Officer at Glooko stated, "We are so pleased to welcome Prakash to our Executive Leadership Team. He brings an impressive track record of leading successful teams in building healthcare enterprise systems and scaling those systems for rapid growth. Even in a place such as Silicon Valley, his credentials stand out. We are excited to see him take Glooko's products to next-level." Johannesson continued, "Additionally, we are very proud of the contributions that Kyle Brown, our outgoing CTO has made at Glooko. His impact in his time here has been very positive to building Glooko's platforms to where they are today for our worldwide patients and healthcare providers. We wish him all the best and a very happy retirement." About Glooko Glooko is transforming digital health by connecting people with diabetes and related conditions and their healthcare teams, enabling telehealth, clinical research, and improved collaboration. The company's software platforms empower the management of diabetes and other chronic conditions by collecting and unlocking the power of data from blood-glucose meters, CGMs, insulin pumps, connected insulin pens, blood pressure cuffs, nutrition apps, connected weight scales and activity trackers – bringing insights together in one place. Data is easily uploaded – remotely via app or in-clinic, securely shared, and visualized in actionable charts and graphs. This creates a solid foundation enabling collaboration and confident treatment decisions. The platforms are compatible with over 95% of global diabetes devices along with health monitoring devices, giving people with diabetes and other chronic conditions and their care teams the freedom of choice. Over 3 million users have benefitted from health data insights using Glooko's solutions, which are trusted by world leaders in diabetes and chronic care, and used in 28 countries across 21 languages. Learn more at glooko.com . Media Contacts: